SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
ADVANCED MEDICAL OPTICS, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Shares of Common Stock, par value $.01 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
00763M108
--------------------------------------------------------------------------------
(CUSIP Number)
July 9, 2002
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
1
------------------- --------------------
CUSIP No. 00763M108 13G
------------------- --------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Greenlight Capital, L.L.C.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES 2,681,500
BENEFICIALLY -----------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH
REPORTING 0
PERSON WITH -----------------------------------------------------
7 SOLE DISPOSITIVE POWER
2,681,500
-----------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,681,500
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.3%**
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
** SEE ITEM 4(b).
2
------------------- --------------------
CUSIP No. 00763M108 13G
------------------- --------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
David Einhorn
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S. Citizen
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES 2,681,500
BENEFICIALLY -----------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH
REPORTING 0
PERSON WITH -----------------------------------------------------
7 SOLE DISPOSITIVE POWER
2,681,500
-----------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,681,500
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.3%**
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
** SEE ITEM 4(b).
3
------------------- --------------------
CUSIP No. 00763M108 13G
------------------- --------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Jeffrey A. Keswin
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S. Citizen
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES 2,681,500
BENEFICIALLY -----------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH
REPORTING 0
PERSON WITH -----------------------------------------------------
7 SOLE DISPOSITIVE POWER
2,681,500
-----------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,681,500
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.3%**
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
** SEE ITEM 4(b).
4
SCHEDULE 13G
This Schedule 13G (the "Schedule 13G") is being filed on behalf of
Greenlight Capital, L.L.C., a Delaware limited liability company ("Greenlight"),
and Mr. David Einhorn and Mr. Jeffrey A. Keswin, the principals of Greenlight,
relating to shares of common stock of Advanced Medical Optics, Inc., a Delaware
corporation (the "Issuer").
This Schedule 13G relates to shares of Common Stock of the Issuer
purchased by Greenlight for the account of (i) Greenlight Capital, L.P.
("Greenlight Fund"), of which Greenlight is the general partner, (ii) Greenlight
Capital Qualified, L.P. ("Greenlight Qualified"), of which Greenlight is the
general partner and (iii) Greenlight Capital Offshore, Ltd. ("Greenlight
Offshore"), to which Greenlight acts as investment advisor.
ITEM 1(a) NAME OF ISSUER.
Advanced Medical Optics, Inc.
ITEM 1(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES.
1700 E. St. Andrew Place
Santa Ana, California 92799
ITEM 2(a) NAME OF PERSON FILING.
Greenlight Capital, L.L.C. ("Greenlight"), David Einhorn and
Jeffrey A. Keswin
ITEM 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE, RESIDENCE.
420 Lexington Ave., Suite 1740
New York, New York 10170
ITEM 2(c) CITIZENSHIP OR PLACE OF ORGANIZATION.
Greenlight is a limited liability company organized under the
laws of the State of Delaware. David Einhorn and Jeffrey A.
Keswin are the principals of Greenlight and are United States
citizens.
ITEM 2(d) TITLE OF CLASS OF SECURITIES.
Common Stock, par value $0.01 per share (the "Common Stock").
ITEM 2(e) CUSIP NUMBER.
00763M108
5
ITEM 3 REPORTING PERSON.
Inapplicable.
ITEM 4 OWNERSHIP.
(a) Greenlight and Messrs. Einhorn and Keswin are the
beneficial owners of 2,681,500 shares of Common
Stock.
(b) Greenlight and Messrs. Einhorn and Keswin are the
beneficial owners of 9.3% of the outstanding shares
of Common Stock. This percentage is determined by
dividing 2,681,500 by 28,723,512, the number of
shares of Common Stock issued and outstanding as of
July 22, 2002, as reported in the Issuer's
registration statement on Form S-4 filed August 2,
2002.
(c) Greenlight has the sole power to vote and dispose of
the 2,681,500 shares of Common Stock beneficially
owned by it. As the principals of Greenlight, Messrs.
Einhorn and Keswin may direct the vote and
disposition of the 2,681,500 shares of Common Stock
beneficially owned by Greenlight.
ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
Inapplicable.
ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
PERSON.
Inapplicable.
ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY.
Inapplicable.
ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Inapplicable.
ITEM 9 NOTICE OF DISSOLUTION OF GROUP.
Inapplicable.
ITEM 10 CERTIFICATION.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the
securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.
6
EXHIBITS EXHIBIT 1
Joint Filing Agreement dated August 13, 2002, between
Greenlight, David Einhorn and Jeffrey A. Keswin.
7
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: August 13, 2002
Greenlight Capital, L.L.C.
By: /s/ JEFFREY A. KESWIN
-----------------------------------
JEFFREY A. KESWIN, Managing Member
/s/ DAVID EINHORN
----------------------------------------
David Einhorn
/s/ JEFFREY A. KESWIN
----------------------------------------
Jeffrey A. Keswin
8
EXHIBIT 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of
1934, as amended, the undersigned agree to the joint filing on behalf of each of
them of a Statement on Schedule 13G (including any and all amendments thereto)
with respect to the Common Stock, par value $.01 per share, of Advanced Medical
Optics, Inc., and further agree that this Joint Filing Agreement shall be
included as an Exhibit to such joint filings.
The undersigned further agree that each party hereto is responsible for
the timely filing of such Statement on Schedule 13G and any amendments thereto,
and for the accuracy and completeness of the information concerning such party
contained therein; provided, however, that no party is responsible for the
accuracy or completeness of the information concerning any other party, unless
such party knows or has reason to believe that such information is inaccurate.
This Joint Filing Agreement may be signed in counterparts with the same
effect as if the signature on each counterpart were upon the same instrument.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of
August 13, 2002.
Greenlight Capital, L.L.C.
By: /s/ JEFFREY A. KESWIN
-----------------------------------
JEFFREY A. KESWIN, Managing Member
/s/ DAVID EINHORN
----------------------------------------
David Einhorn
/s/ JEFFREY A. KESWIN
----------------------------------------
Jeffrey A. Keswin
9